Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESL.L Regulatory News (ESL)

  • There is currently no data for ESL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues outlook on CREALOGIX Group (CLXN)

21 Nov 2018 15:29

Edison Investment Research Limited Edison issues outlook on CREALOGIX Group (CLXN) 21-Nov-2018 / 15:29 GMT/BST


London, UK, 21 November 2018

Edison issues outlook on CREALOGIX Group (CLXN)

CREALOGIX (CLXN) has established a strong track record of delivering software solutions to the banking industry in Switzerland and is transitioning the business to international markets. FY18 numbers were below expectations, mainly due to the faster than anticipated switch to SaaS, which spreads out revenue. International revenues represent 57% of the total (50% in FY17). CREALOGIX acquired the 80% remainder of Elaxy BS&S in July, have acquired Innofis to target the Middle Eastern markets earlier this year. The stable, cash-generative nature of Elaxy BS&S balances the higher-risk, stronger growth profile of Innofis. Given the attractive industry dynamics, and with CREALOGIX ideally positioned to capitalise on these, the shares look attractive on c 21x our FY20e EPS.

A DCF scenario incorporating 10% organic revenue CAGR over 2019-29e falling thereafter to 2%, operating margins tapering up to a level of 15% from FY22e, along with a 9% WACC, would suggest a valuation of CHF217, 68% above the current share price. Increasing the margin target to 20% lifts the valuation to CHF284, while reducing the margin to 10% cuts it to CHF150. These valuations are after the dilution impact from the outstanding convertible bonds.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Richard Jeans, +44 (0)20 3077 5700Katherine Thompson, +44 (0)20 3077 5730tech@edisongroup.comLearn more at www.edisongroup.com and connect with Edison on:LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_ResYouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

749693 21-Nov-2018 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
23rd Mar 20202:05 pmRNSSecond Price Monitoring Extn
23rd Mar 20202:00 pmRNSPrice Monitoring Extension
23rd Mar 202011:05 amRNSSecond Price Monitoring Extn
23rd Mar 202011:00 amRNSPrice Monitoring Extension
23rd Mar 20209:05 amRNSSecond Price Monitoring Extn
23rd Mar 20209:00 amRNSPrice Monitoring Extension
16th Mar 20204:08 pmRNSHolding(s) in Company
9th Mar 20209:05 amRNSSecond Price Monitoring Extn
9th Mar 20209:00 amRNSPrice Monitoring Extension
2nd Mar 20204:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20204:36 pmRNSPrice Monitoring Extension
2nd Mar 20202:05 pmRNSSecond Price Monitoring Extn
2nd Mar 20202:00 pmRNSPrice Monitoring Extension
2nd Mar 202011:05 amRNSSecond Price Monitoring Extn
2nd Mar 202011:00 amRNSPrice Monitoring Extension
2nd Mar 20209:05 amRNSSecond Price Monitoring Extn
2nd Mar 20209:00 amRNSPrice Monitoring Extension
27th Feb 20205:52 pmRNSHolding(s) in Company
27th Feb 20205:39 pmRNSHolding(s) in Company
27th Feb 20209:00 amRNSPrice Monitoring Extension
26th Feb 20207:30 amRNSRestoration - Eddie Stobart Logistics Plc
26th Feb 20207:00 amRNSDirectorate Update
26th Feb 20207:00 amRNSInterim Results for six months ended 31 May 2019
17th Jan 20204:55 pmRNSCompany Update
17th Dec 201910:00 amRNSCompany Update
10th Dec 20198:16 amRNSCompletion of Disposal
6th Dec 201912:23 pmRNSResults of General Meeting & Proposed Transaction
6th Dec 20197:00 amRNSFCA Approval for Change in Control
5th Dec 201911:34 amRNSHolding(s) in Company
4th Dec 20192:54 pmRNSResponse to TVFB (3) Limited
3rd Dec 20193:54 pmRNSHolding(s) in Company
2nd Dec 20194:49 pmRNSHolding(s) in Company
2nd Dec 20197:00 amRNSUpdate on proposal
29th Nov 20195:46 pmRNSHolding(s) in Company
29th Nov 20194:30 pmRNSResponse to TVFB (3) Limited
26th Nov 201911:20 amRNSForm 8.5 (EPT/RI) - Wincanton plc
25th Nov 20195:13 pmRNSWincanton plc - Decision not to make an offer
25th Nov 20193:20 pmRNSDecision not to make an offer
25th Nov 201911:36 amRNSForm 8.5 (EPT/RI) - Eddie Stobart Logistics plc
25th Nov 201911:31 amRNSForm 8.5 (EPT/RI) - Wincanton plc
21st Nov 201911:11 amRNSForm 8.5 (EPT/RI) - Wincanton plc
20th Nov 20193:33 pmRNSPosting of Circular & Notice of General Meeting
19th Nov 201911:37 amRNSForm 8.5 (EPT/RI) - Wincanton plc
18th Nov 201911:34 amRNSForm 8.5 (EPT/RI)Wincanton plc
15th Nov 20193:27 pmRNSUpdate re Possible Offer
15th Nov 20192:33 pmRNSWincanton plc - extension of PUSU deadline
15th Nov 20197:00 amRNSCompany & Offer Update; Injection of new financing
14th Nov 20196:16 pmRNSAppointment to the Board
14th Nov 20194:51 pmRNSDBAY Advisors Limited - Extension of PUSU deadline
14th Nov 201910:52 amRNSForm 8.5 (EPT/RI) Wincanton plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.